aTyr Pharma Inc (NASDAQ:LIFE) Reported Basic Consolidated EPS Of $-3.029 For Period Ended 2015-12-31

0

The annual basic consolidated EPS for aTyr Pharma Inc (NASDAQ:LIFE) for the period ended 2015-12-31 was $-3.029. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-12-31 was $-3.029.

EPS from continuing operations

Coming to basic EPS from continuing operations, aTyr Pharma Inc (NASDAQ:LIFE) reported $-3.029 for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-12-31 stood at $-3.029.

EPS contribution from parent

For the annual period ended 2015-12-31, aTyr Pharma Inc (NASDAQ:LIFE) received basic EPS of $-3.029 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-12-31 was $-3.029.

Basic net EPS

For the annual period ended 2015-12-31, aTyr Pharma Inc (NASDAQ:LIFE) reported basic net EPS of $-3.03. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-12-31 stood at $-3.03.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-12-31 stood at $-3.029. For the quarter ended 2015-12-31, consolidated diluted EPS was $-3.029.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $-3.029 for the period ended 2015-12-31. Diluted EPS from continuing operations for the quarter ended 2015-12-31 was $-3.029.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-12-31 was $-3.03. For the quarterly period ended 2015-12-31, net diluted EPS was $-3.03.

Diluted EPS from parent

From the parent company, aTyr Pharma Inc (NASDAQ:LIFE) received diluted EPS of $-3.029 for the annual period ended 2015-12-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-12-31 was $-3.029.

aTyr Pharma Inc (NASDAQ:LIFE) posted net basic EPS reading of $-3.03 for the annual period ended 2015-12-31. For the quarter, basic net EPS of $-3.03 was for the quarter ended 2015-12-31.

Net diluted EPS for aTyr Pharma Inc (NASDAQ:LIFE) for the annual period ended 2015-12-31 was $-3.03. The company also reported net diluted EPS reading of $-3.03 for the quarter ended 2015-12-31.

The annual average basic shares outstanding for the period ended 2015-12-31 is 15.838 while for the quarter ended 2015-12-31 is 15.838.

The diluted shares outstanding for the fiscal year ended is 2015-12-31 is 15.838 while for the quarter ended 2015-12-31 is 15.838.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 15 times, 1 visits today)